EP 1526855 A2 20050504 - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
Title (en)
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR BEHANDLUNG DER HARNINKONTINENZ
Title (fr)
COMPOSITIONS PHARMACEUTIQUES DESTINEES AU TRAITEMENT DE L'INCONTINENCE URINAIRE
Publication
Application
Priority
- FR 0302471 W 20030806
- FR 0210058 A 20020807
Abstract (en)
[origin: FR2843303A1] Composition for treating urinary incontinence comprises oxybutynine (I; 4-diethylamino-2-butynyl 2-cyclohexyl-2-hydroxyphenylacetate), optionally a moderated (poorly resorbed) estrogen (II) and an inert excipient or vehicle, for rectal or vaginal administration.
IPC 1-7
IPC 8 full level
A61K 9/52 (2006.01); A61K 31/565 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01)
CPC (source: EP US)
A61K 31/565 (2013.01 - EP US); A61P 13/00 (2017.12 - EP); A61P 13/10 (2017.12 - EP)
Citation (search report)
See references of WO 2004014360A2
Citation (examination)
- WO 03026564 A2 20030403 - PHARMACIA AB [SE], et al
- WO 2004073679 A1 20040902 - MULHOLLAND S GRANT [US]
- WO 2004043429 A1 20040527 - UPJOHN CO [US], et al
- WO 2004052440 A1 20040624 - COLOPLAST AS [DK], et al
- WO 2004084879 A1 20041007 - DYNOGEN PHARMACEUTICALS INC [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
FR 2843303 A1 20040213; FR 2843303 B1 20060121; AU 2003283153 A1 20040225; AU 2003283153 A8 20040225; EP 1526855 A2 20050504; US 2006100182 A1 20060511; WO 2004014360 A2 20040219; WO 2004014360 A3 20040408
DOCDB simple family (application)
FR 0210058 A 20020807; AU 2003283153 A 20030806; EP 03756527 A 20030806; FR 0302471 W 20030806; US 52413105 A 20050913